Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasms 1Parkinson Disease 1Neuroendocrine Tumors 1

Interventions

Thyroidectomy 4Iodine-131 4trametinib 3dabrafenib 3apatinib 3anlotinib 2Surgical Procedures, Operative 2Blood Specimen Collection 2Biopsy, Large-Core Needle 2toripalimab 1tislelizumab 1surufatinib 1regorafenib 1penpulimab 1pembrolizumab 1pazopanib 1palbociclib 1olaparib 1lenvatinib 1famitinib 1camrelizumab 1Ultrasonography 1Thyroxine 1Thyrotropin Alfa 1Sunitinib 1Second Harmonic Generation Microscopy 1Routinely Collected Health Data 1Rosiglitazone 1Robotic Surgical Procedures 1Radiotherapy, Intensity-Modulated 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Thyroid Neoplasms × Iodine-123 × Clear all
NCT02418247 2017-01-20

Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer

National Cancer Center, Korea

Phase 2/3 Unknown
556 enrolled
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡